Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDEST.L Regulatory News (DEST)

  • There is currently no data for DEST
Date   Source Headline
25th Jan 20227:00 amRNSGrant of share options
24th Jan 20227:00 amRNSClinical and commercial opportunity of NTCD-M3
21st Jan 20227:15 amRNSDestiny Pharma Lancet Report
17th Jan 20227:00 amRNSStrategy/Company/Ops Update
21st Dec 20214:35 pmRNSExercise of Options and Total Voting Rights
17th Dec 20219:46 amRNSGrant of share options
15th Nov 20212:26 pmRNSDirectorate Change
4th Nov 20217:00 amRNSSAB Member Prof. Gerding is Keynote at C.diff Conf
18th Oct 20217:00 amRNSStudy gives strong support for potential of XF-73
27th Sep 20213:18 pmRNSDirector/PDMR Shareholding
27th Sep 20217:00 amRNSExpansion of clinical pipeline
9th Sep 20217:00 amRNSInterim results for six months ended 30 June 2021
23rd Aug 20217:00 amRNSNotice of Interim Results
2nd Aug 20217:00 amRNSSecondary endpoint analysis from Phase 2b trial
9th Jul 20218:00 amRNSXF-73 Phase 2b data to be presented at ECCMID
6th Jul 20217:00 amRNSNTCD-M3 RD Agreement with US Dept Veterans Affairs
2nd Jul 20218:00 amRNSScientific Advisor Gerding chairs C Diff symposium
29th Jun 20218:24 amRNSDEST to present at Shares & AJ Bell Webinar 6/7/21
10th Jun 20215:00 pmRNSDirector Dealing
10th Jun 20217:00 amRNSXF-73 data abstract to be presented at 2021 ECCMID
7th Jun 20217:00 amRNSDestiny Pharma welcomes G7’s Communique on AMR
3rd Jun 202112:03 pmRNSResult of AGM
2nd Jun 20217:00 amRNSPositive update on microbiome therapeutic NTCD-M3
25th May 20217:00 amRNSFurther information re AGM
19th May 20217:00 amRNSNotice to Register for 2021 AGM
6th May 202110:00 amRNSConference Attendance for May 2021
4th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
30th Apr 20217:00 amRNSDirector Dealing
23rd Apr 20217:00 amRNSDirector Dealing
15th Apr 20218:00 amRNSFY 2020 Investor Presentation
14th Apr 20217:00 amRNSFinal Results
29th Mar 202112:45 pmRNSExercise of Options and Total Voting Rights
29th Mar 202112:00 pmRNSDestiny Pharma to Join Equity Development Webinar
29th Mar 202111:06 amRNSSecond Price Monitoring Extn
29th Mar 202111:00 amRNSPrice Monitoring Extension
29th Mar 202110:15 amRNSExercise of Options and Total Voting Rights
29th Mar 20219:06 amRNSSecond Price Monitoring Extn
29th Mar 20219:00 amRNSPrice Monitoring Extension
29th Mar 20217:00 amRNSDestiny Pharma Reports Positive Phase 2b Results
16th Mar 20217:00 amRNSNotice of Results
15th Mar 20217:00 amRNSDestiny Pharma Announces Agreement with NIAID
10th Mar 20212:15 pmRNSExercise of Options and Total Voting Rights
10th Mar 20217:00 amRNSDestiny Pharma CSO Joins UKRI COVID-19 Taskforce
10th Feb 20212:05 pmRNSSecond Price Monitoring Extn
10th Feb 20212:00 pmRNSPrice Monitoring Extension
3rd Feb 20217:00 amRNSBrazilian Patent Granted for XF-73 nasal gel
2nd Feb 20217:05 amRNSDestiny Pharma to join panel discussion at LSX
2nd Feb 20217:00 amRNSDestiny Pharma Appoints Professor Mark Wilcox
21st Jan 20214:41 pmRNSSecond Price Monitoring Extn
21st Jan 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.